Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 1
1993 1
1995 1
1996 2
1997 2
1998 4
1999 3
2000 3
2001 4
2002 5
2003 3
2004 6
2005 7
2006 1
2007 5
2008 4
2009 10
2010 6
2011 4
2012 12
2013 5
2014 7
2015 18
2016 9
2017 7
2018 11
2019 7
2020 7
2021 9
2022 4
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Adult Atypical Meningioma"
Page 1
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Brachman D, Jenrette JM, De Groot J, Bovi JA, Werner-Wasik M, Knisely JPS, Mehta MP. Rogers L, et al. J Neurosurg. 2018 Jul;129(1):35-47. doi: 10.3171/2016.11.JNS161170. Epub 2017 Oct 6. J Neurosurg. 2018. PMID: 28984517 Free PMC article. Clinical Trial.
METHODS NRG Oncology RTOG 0539 was a Phase II clinical trial allocating meningioma patients to 1 of 3 prognostic groups and management strategies according to WHO grade, recurrence status, and resection extent. ...Clinical trial registration no. …
METHODS NRG Oncology RTOG 0539 was a Phase II clinical trial allocating meningioma patients to 1 of 3 prognostic groups …
Stereotactic Radiosurgery for Intracranial Meningiomas.
Pikis S, Mantziaris G, Dumot C, Xu Z, Sheehan J. Pikis S, et al. Neurosurg Clin N Am. 2023 Jul;34(3):455-462. doi: 10.1016/j.nec.2023.02.010. Epub 2023 Apr 7. Neurosurg Clin N Am. 2023. PMID: 37210134 Review.
Meningiomas are thought to originate from the meningothelial cells of the arachnoid mater and are the most common primary brain tumor in adults. ...Intracranial meningiomas are the most commonly benign, WHO Grade I neoplasms. Atypical and anaplastic ar …
Meningiomas are thought to originate from the meningothelial cells of the arachnoid mater and are the most common primary brain tumor …
Gout Storm.
Martins D, Tonon CR, Pacca RL, Matchil NL, Junior LAJ, Queiroz DS, Pereira FWL, Silva AM, Padovese V, Padovani de Toledo Moraes M, Luiz da Silva D, Cardoso Nóbrega V, Curcelli EC, Okoshi MP. Martins D, et al. Am J Case Rep. 2021 Sep 20;22:e932683. doi: 10.12659/AJCR.932683. Am J Case Rep. 2021. PMID: 34855717 Free PMC article.
Despite being one of the oldest diseases in the world, gout pathophysiology is incompletely understood and clinical features are still surprising. Recent reports describe unusual manifestations including atypical joints involvement, tenosynovitis, panniculitis, and …
Despite being one of the oldest diseases in the world, gout pathophysiology is incompletely understood and clinical features are stil …
Management of Central and Peripheral Nervous System Tumors in Patients with Neurofibromatosis.
Brown R. Brown R. Curr Oncol Rep. 2023 Dec;25(12):1409-1417. doi: 10.1007/s11912-023-01451-z. Epub 2023 Oct 31. Curr Oncol Rep. 2023. PMID: 37906356 Review.
Some research suggests that alternative Mek inhibitors and other mixed tyrosine kinase inhibitors may have better efficacy in adults. Vascular endothelial growth factor (VEGF) inhibitor bevacizumab can prolong hearing and delay the need for surgery in NF2 patients with bil …
Some research suggests that alternative Mek inhibitors and other mixed tyrosine kinase inhibitors may have better efficacy in adults. …
Salvage therapy outcomes for atypical meningioma.
Chen WC, Hara J, Magill ST, Wu A, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Raleigh DR, Braunstein SE. Chen WC, et al. J Neurooncol. 2018 Jun;138(2):425-433. doi: 10.1007/s11060-018-2813-9. Epub 2018 Feb 26. J Neurooncol. 2018. PMID: 29480505
Atypical menginomas demonstrate increased clinical aggressiveness characterized by recurrence and diminished survival. The optimal management of atypical meningioma in the recurrent setting is especially not well defined. ...
Atypical menginomas demonstrate increased clinical aggressiveness characterized by recurrence and diminished survival. The opt …
Advances in meningioma therapy.
Norden AD, Drappatz J, Wen PY. Norden AD, et al. Curr Neurol Neurosci Rep. 2009 May;9(3):231-40. doi: 10.1007/s11910-009-0034-5. Curr Neurol Neurosci Rep. 2009. PMID: 19348712 Review.
Meningiomas are the most common primary brain tumors in adults. Most of them are benign (World Health Organization grade I), slow-growing lesions, but some are classified as atypical (WHO grade II) or malignant (WHO grade III). ...Radiotherapy effectively red …
Meningiomas are the most common primary brain tumors in adults. Most of them are benign (World Health Organization grade I), s …
Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Zhu H, Bi WL, Aizer A, Hua L, Tian M, Den J, Tang H, Chen H, Wang Y, Mao Y, Dunn IF, Xie Q, Gong Y. Zhu H, et al. Cancer Med. 2019 Jan;8(1):13-20. doi: 10.1002/cam4.1531. Cancer Med. 2019. PMID: 30680963 Free PMC article.
The effect of adjuvant radiotherapy in management for high-grade meningiomas, especially atypical meningiomas, remains controversial. We aimed to explore the role of adjuvant radiotherapy in this population. A total of 162 adults with high-grade men …
The effect of adjuvant radiotherapy in management for high-grade meningiomas, especially atypical meningiomas, remains …
Treatment of meningioma: an update.
D'Ambrosio AL, Bruce JN. D'Ambrosio AL, et al. Curr Neurol Neurosci Rep. 2003 May;3(3):206-14. doi: 10.1007/s11910-003-0080-3. Curr Neurol Neurosci Rep. 2003. PMID: 12691625 Review.
Additionally, advances in the understanding of molecular biologic and biochemical mechanisms underlying meningioma growth offer unique opportunities for potential treatment adjuncts for atypical and malignant tumors. This review discusses current understanding of …
Additionally, advances in the understanding of molecular biologic and biochemical mechanisms underlying meningioma growth offer uniqu …
High-dose radiation-induced meningiomas.
Salvati M, Cervoni L, Puzzilli F, Bristot R, Delfini R, Gagliardi FM. Salvati M, et al. Surg Neurol. 1997 May;47(5):435-41; discussion 441-2. doi: 10.1016/s0090-3019(96)00360-6. Surg Neurol. 1997. PMID: 9131025
The first disease is acute lymphocytic leukemia (ALL) in 40% of cases. Radiation induced meningiomas are atypical in four cases. Recurrence was observed in one case without malignant transformation. CONCLUSION: High-dose radiation-induced meningiomas have the …
The first disease is acute lymphocytic leukemia (ALL) in 40% of cases. Radiation induced meningiomas are atypical in four case …
Cyproterone acetate and meningioma: a nationwide-wide population based study.
Champeaux-Depond C, Weller J, Froelich S, Sartor A. Champeaux-Depond C, et al. J Neurooncol. 2021 Jan;151(2):331-338. doi: 10.1007/s11060-020-03672-9. Epub 2021 Jan 4. J Neurooncol. 2021. PMID: 33394263

Middle skull base was the most common (39%) location with a anterior skull base insertion being also far more common compared to the usual population with 21.9% of the tumour. This skull base predominance of CPA-associated meningioma is highly significant (p < 0.001). I

…
Middle skull base was the most common (39%) location with a anterior skull base insertion being also far more common compared to the usual p …
154 results